Skip to main content

Immunome Inc S-3ASR, filed Nov 9, 2026

Immunome Inc. (IMNM)

Immunome registered 4,425,487 common shares for BMS to resell after paying $20.0 million in cash for an amendment eliminating milestone and royalty obligations under its license agreement. AI summary

S-3ASR 2026-11-09
View Original
Added on November 09, 2026